Phreesia (NYSE:PHR – Get Rating) had its target price dropped by SVB Leerink from $29.00 to $22.00 in a report issued on Friday, Stock Target Advisor reports. The brokerage currently has a “market perform” rating on the stock. SVB Leerink’s target price points to a potential upside of 15.79% from the stock’s previous close.
A number of other equities analysts also recently commented on the company. Citigroup lowered their price objective on Phreesia from $54.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, March 31st. Royal Bank of Canada lowered their price objective on Phreesia from $51.00 to $29.00 and set a “sector perform” rating for the company in a research report on Thursday, April 7th. JPMorgan Chase & Co. lowered their price objective on Phreesia from $51.00 to $42.00 in a research report on Thursday, March 31st. Canaccord Genuity Group lowered their price objective on Phreesia from $81.00 to $49.00 in a research report on Thursday, March 31st. Finally, Canaccord Genuity Group lowered their price target on Phreesia from $81.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, March 31st. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $49.59.
NYSE PHR opened at $19.00 on Friday. The company has a market cap of $973.56 million, a P/E ratio of -8.15 and a beta of 1.39. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.65 and a quick ratio of 5.65. The stock has a 50-day moving average of $23.04 and a two-hundred day moving average of $33.39. Phreesia has a 1-year low of $13.19 and a 1-year high of $76.10.
In other Phreesia news, General Counsel Allison C. Hoffman sold 3,909 shares of the business’s stock in a transaction that occurred on Monday, May 9th. The stock was sold at an average price of $17.07, for a total value of $66,726.63. Following the completion of the sale, the general counsel now owns 115,099 shares in the company, valued at $1,964,739.93. The sale was disclosed in a document filed with the SEC, which is available through this link. 5.50% of the stock is currently owned by insiders.
Hedge funds have recently made changes to their positions in the stock. Exane Derivatives grew its holdings in Phreesia by 5,845.5% in the fourth quarter. Exane Derivatives now owns 654 shares of the company’s stock valued at $27,000 after purchasing an additional 643 shares during the last quarter. Clearstead Advisors LLC acquired a new stake in Phreesia in the third quarter valued at $29,000. Sageworth Trust Co of South Dakota acquired a new stake in Phreesia in the fourth quarter valued at $33,000. First Horizon Advisors Inc. grew its holdings in Phreesia by 573.7% in the fourth quarter. First Horizon Advisors Inc. now owns 923 shares of the company’s stock valued at $38,000 after purchasing an additional 786 shares during the last quarter. Finally, Advisor Group Holdings Inc. grew its holdings in Phreesia by 63.4% in the fourth quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company’s stock valued at $55,000 after purchasing an additional 512 shares during the last quarter. 94.29% of the stock is currently owned by hedge funds and other institutional investors.
About Phreesia (Get Rating)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
- Get a free copy of the StockNews.com research report on Phreesia (PHR)
- Alibaba Group: Rallying on Fundamentals & Improved Macro Backdrop
- Investing in Chewy Will Require More Than One Earnings Report
- JFrog Stock is Ready to Leap
- Hormel Foods Sends A Message To The Market
- PVH Corp. Looks Sharp For A Major Reversal
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.